1227158-85-1 | Bay 87-2243

Packsize	Purity	Availability	Price	Discounted Price
1mg	99%	in stock	$25.00	$17.00
5mg	99%	in stock	$50.00	$35.00
10mg	99%	in stock	$70.00	$49.00
25mg	99%	in stock	$118.00	$82.00
50mg	99%	in stock	$178.00	$124.00
100mg	99%	in stock	$280.00	$196.00

Description

• Catalog Number: AE35589
• Chemical Name: Bay 87-2243
• CAS Number: 1227158-85-1
• Molecular Formula: C26H26F3N7O2
• Molecular Weight: 525.5255
• MDL Number: MFCD28143915
• SMILES: Cc1cc(nn1Cc1ccnc(c1)N1CCN(CC1)C1CC1)c1onc(n1)c1ccc(cc1)OC(F)(F)F

Computed Properties

• Complexity: 774
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 38
• Hydrogen Bond Acceptor Count: 11
• Rotatable Bond Count: 7
• XLogP3: 4.7

Upstream Synthesis Route

The compound 1-Cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]piperazine, or $name$, is a versatile molecule with significant applications in chemical synthesis. Due to its unique structure, $name$ serves as a valuable building block in the creation of novel organic compounds. Specifically, its combination of cyclic, aromatic, and heterocyclic functional groups allows for diverse reactivity and potential for the synthesis of complex molecules.In organic synthesis, $name$ can act as a key intermediate in the construction of pharmaceuticals, agrochemicals, and materials with tailored properties. Its piperazine core provides opportunities for functionalization and diversification, enabling the introduction of various substituents for structure-activity relationship studies. Additionally, the presence of pyridine, oxadiazole, and pyrazole moieties enhances the potential for biological activity and interaction with biological targets.Furthermore, the trifluoromethoxyphenyl group in $name$ offers unique properties in terms of both steric hindrance and electronic effects, making it a valuable tool for fine-tuning the reactivity and selectivity of chemical reactions. Overall, the strategic incorporation of 1-Cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]piperazine into synthetic pathways can lead to the development of molecules with enhanced biological activity, improved chemical properties, and potential for applications in various industries.

Literature

• BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

  Cancer medicine 20131001